Contract 75N95023P00723
Pointcare Systems Inc · Department Of Health And Human Services · September 7, 2023
Pointcare Systems Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 7, 2023 for $21,000 of work in biological product (except diagnostic) manufacturing. It was awarded under a small business set-aside. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 27, 2023.
Contract details
- PIID
- 75N95023P00723
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Competed Under Sap
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Special Studies/Analysis- Chemical/Biological
- First action
- September 7, 2023
- Latest action
- December 27, 2023
Description
SYNTHESIS OF TERT-BUTYL (R)-3-(5-OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-3- YL)PIPERIDINE-1-CARBOXYLATE IN 75 GRAM QUANTITY.
Modification timeline
-
December 27, 2023Mod P00001$10.0K
-
September 7, 2023Base award$10.9K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Bio-Rad Laboratories, Inc. | Department Of Health And Human Services | March 31, 2026 | $20.6K |
| Georgia Tech Research Corp | Department Of Health And Human Services | March 28, 2026 | $145.8K |
| Seqirus Inc | Department Of Health And Human Services | March 25, 2026 | $23.7K |
| Seqirus Inc | Department Of Health And Human Services | March 24, 2026 | $0 |
| Battelle Memorial Institute | Department Of Health And Human Services | March 19, 2026 | $2.80M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 19, 2026 | $53.21M |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Pfizer Inc | 3 | $15.27B |
| 2 | Sanofi Vaccines Us Inc. | 606 | $9.38B |
| 3 | Regeneron Pharmaceuticals Inc | 1 | $5.57B |
| 4 | Merck Sharp & Dohme Corp. | 56 | $3.99B |
| 5 | Emergent Biodefense Operations Lansing Llc | 16 | $3.34B |
| 6 | Merck Sharp & Dohme Llc | 15 | $3.33B |
| 7 | Pfizer Inc. | 25 | $3.11B |
| 8 | Glaxosmithkline Holdings (Americas) Inc. | 109 | $2.24B |
| 9 | Modernatx, Inc. | 1 | $1.75B |
| 10 | Bavarian Nordic A/S | 1 | $1.01B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N95023P00723?
Contract 75N95023P00723 is a federal contract awarded to Pointcare Systems Inc by Department Of Health And Human Services on September 7, 2023 for $21,000 of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75N95023P00723?
Pointcare Systems Inc won contract 75N95023P00723 from Department Of Health And Human Services.
How much is contract 75N95023P00723 worth?
Contract 75N95023P00723 has obligated $21,000 to date.